rs4938445

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_022003.4(FXYD6):​c.-6+2304C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.325 in 152,078 control chromosomes in the GnomAD database, including 8,132 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 8132 hom., cov: 32)

Consequence

FXYD6
NM_022003.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.948

Publications

10 publications found
Variant links:
Genes affected
FXYD6 (HGNC:4030): (FXYD domain containing ion transport regulator 6) This gene encodes a member of the FXYD family of transmembrane proteins. This particular protein encodes phosphohippolin, which likely affects the activity of Na,K-ATPase. Multiple alternatively spliced transcript variants encoding the same protein have been described. Related pseudogenes have been identified on chromosomes 10 and X. Read-through transcripts have been observed between this locus and the downstream sodium/potassium-transporting ATPase subunit gamma (FXYD2, GeneID 486) locus.[provided by RefSeq, Feb 2011]
FXYD6-FXYD2 (HGNC:39978): (FXYD6-FXYD2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring FXYD domain-containing ion transport regulator 6 (GeneID 53826) and sodium/potassium-transporting ATPase subunit gamma (GeneID 486) genes on chromosome 11. One read-through transcript produces a fusion protein that shares sequence identity with each individual gene product, while another read-through transcript encodes a protein that has a distinct C-terminus and only shares sequence identity with the upstream locus (GeneID 53826). [provided by RefSeq, Aug 2011]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_022003.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.352 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022003.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FXYD6
NM_022003.4
MANE Select
c.-6+2304C>T
intron
N/ANP_071286.1Q9H0Q3-1
FXYD6-FXYD2
NM_001204268.3
c.-6+2304C>T
intron
N/ANP_001191197.1A0A087WZ82
FXYD6-FXYD2
NM_001243598.4
c.-6+2304C>T
intron
N/ANP_001230527.1A0A0A6YYL5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FXYD6
ENST00000526014.6
TSL:1 MANE Select
c.-6+2304C>T
intron
N/AENSP00000433312.1Q9H0Q3-1
FXYD6-FXYD2
ENST00000614497.5
TSL:3
c.-6+2304C>T
intron
N/AENSP00000482442.1A0A087WZ82
FXYD6
ENST00000260282.8
TSL:1
c.-179+2304C>T
intron
N/AENSP00000260282.4Q9H0Q3-1

Frequencies

GnomAD3 genomes
AF:
0.325
AC:
49384
AN:
151960
Hom.:
8133
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.357
Gnomad AMI
AF:
0.514
Gnomad AMR
AF:
0.265
Gnomad ASJ
AF:
0.337
Gnomad EAS
AF:
0.163
Gnomad SAS
AF:
0.286
Gnomad FIN
AF:
0.369
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.324
Gnomad OTH
AF:
0.311
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.325
AC:
49403
AN:
152078
Hom.:
8132
Cov.:
32
AF XY:
0.325
AC XY:
24149
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.357
AC:
14809
AN:
41452
American (AMR)
AF:
0.265
AC:
4045
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.337
AC:
1169
AN:
3470
East Asian (EAS)
AF:
0.163
AC:
846
AN:
5178
South Asian (SAS)
AF:
0.285
AC:
1371
AN:
4816
European-Finnish (FIN)
AF:
0.369
AC:
3904
AN:
10574
Middle Eastern (MID)
AF:
0.293
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
0.324
AC:
22058
AN:
67990
Other (OTH)
AF:
0.306
AC:
647
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1722
3445
5167
6890
8612
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
492
984
1476
1968
2460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.319
Hom.:
19630
Bravo
AF:
0.316
Asia WGS
AF:
0.245
AC:
854
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.64
DANN
Benign
0.77
PhyloP100
-0.95
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4938445;
hg19: chr11-117745003;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.